Clinical Trials Update: Dec. 7, 2004
Prostate Cancer Peyronie's Disease Multiple Sclerosis
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study to compare the effectiveness of an investigational prostate cancer vaccine and chemotherapy. Volunteers diagnosed with metastatic hormone-refractory prostate cancer may be eligible. Research sites located throughout the United States.
A research study of the physical and psychological ramifications of Peyronie's disease. Men who have been diagnosed or who think they may have Peyronies disease may be eligible. Symptoms include deformity of the penis, painful erection, loss of penile length, and bending and/or curvature. Research sites located in New York, NY; Los Angeles, Calif.; and Chicago, Ill.
A research study of an investigational medication for the treatment of relapsing-remitting multiple sclerosis ("RRMS"). Volunteers between 18 and 55 who have been diagnosed with relapsing-remitting multiple sclerosis and have experienced at least one relapse during the last 12 months may be eligible. Research site located in Henderson, Nev.
Copyright 2004 CenterWatch. All rights reserved.